Activating mutations in the MAP-kinase pathway define non-ossifying fibroma of bone

Daniel Baumhoer1, Michal Kovac1, Jan Sperveslage2

  • 1Bone Tumour Reference Centre, Institute of Pathology, University Hospital Basel and University of Basel, Basel, Switzerland.

The Journal of Pathology
|December 15, 2018
PubMed

Insights

Non-ossifying fibroma (NOF) is a common benign bone lesion. Genetic mutations in KRAS, FGFR1, and NF1 were found in most NOF cases, indicating it is a genetically driven neoplasm.

Area of Science:

  • Skeletal pathology
  • Molecular genetics
  • Oncology

Background:

  • Non-ossifying fibroma (NOF) is the most common benign, self-limiting lesion of the growing skeleton.
  • NOF can occasionally lead to pathologic fractures.

Purpose of the Study:

  • To investigate the molecular pathogenesis of non-ossifying fibroma (NOF).
  • To identify genetic mutations driving NOF development.

Main Methods:

  • DNA sequencing was performed on 59 patients with NOF.
  • Hotspot mutations in KRAS, FGFR1, and NF1 were analyzed.

Main Results:

  • Mutations in KRAS, FGFR1, and NF1 were identified in 81.4% of patients (48/59) with NOF.
  • Allele frequencies for these mutations ranged from 0.04 to 0.61.
  • Findings suggest NOF is a genetically driven neoplasm, often involving activated MAP-kinase signaling.

Conclusions:

  • Non-ossifying fibroma (NOF) is a genetically driven neoplasm, primarily caused by mutations activating the MAP-kinase signaling pathway.
  • This study expands the understanding of benign lesions driven by KRAS and MAP-kinase signaling.

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.1K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.5K
Mutations01:39

Mutations

Overview
94.5K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.5K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.9K
Mutation, Gene Flow, and Genetic Drift01:09

Mutation, Gene Flow, and Genetic Drift

In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
64.2K